Jasper Therapeutics Inc (JSPR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Ronald A. Martell
Employees:
20
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
6505491400

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.

Data derived from most recent annual or quarterly report
Market Cap 74.147 Million Shares Outstanding37.073 Million Avg 30-day Volume 1.373 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.32
Price to Revenue0.0 Debt to Equity0.0 EBITDA-26.759 Million
Price to Book Value1.2866 Operating Margin0.0 Enterprise Value4.74 Million
Current Ratio10.952 EPS Growth0 Quick Ratio10.561
1 Yr BETA 0.1873 52-week High/Low 4.62 / 0.39 Profit Margin0.0
Operating Cash Flow Growth-84.3652 Altman Z-Score1.2816 Free Cash Flow to Firm -21.728 Million
View SEC Filings from JSPR instead.

View recent insider trading info

Jasper Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding JSPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding JSPR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.1 Million total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARTELL RON PRESIDENT, CEO AND DIRECTOR

  • Officer
  • Director
 0 2023-03-17 2

MAHAL JEETINDER SINGH SEE REMARKS

  • Officer
 0 2023-03-17 2

KAPOOR VISHAL

  • Director
 0 2023-02-16 3

CARLYLE GROUP INC.

ABINGWORTH LLP

CARLYLE HOLDINGS I GP INC.

CARLYLE HOLDINGS I GP SUB L.L.C.

CARLYLE HOLDINGS I L.P.

CG SUBSIDIARY HOLDINGS L.L.C.

TC GROUP, LLC

CARLYLE INVESTMENT MANAGEMENT LLC

CARLYLE GENESIS UK LLC

  • 10% Owner
 8,761,891 2023-01-27 2

ROCHE HOLDING LTD

ROCHE FINANCE LTD

  • 10% Owner
 4,549,606 2023-01-25 1

VELAN CAPITAL INVESTMENT MANAGEMENT LP

VELAN CAPITAL MASTER FUND LP

AVEGO HEALTHCARE CAPITAL, L.P.

VELAN CAPITAL HOLDINGS LLC

AVEGO HEALTHCARE CAPITAL HOLDINGS, LLC

AVEGO MANAGEMENT LLC

VELAN CAPITAL MANAGEMENT LLC

VENKATARAMAN BALAJI

MORGAN ADAM

  • 10% Owner
  • SEE FOOTNOTE 1SEE FOOTNOTE 1SEE FOOTNOTE 1SEE FOOTNOTE 1SEE FOOTNOTE 1
10,838,281 2023-01-25 1

CARLYLE GROUP INC.

CARLYLE HOLDINGS I GP INC.

CARLYLE HOLDINGS I GP SUB L.L.C.

CARLYLE HOLDINGS I L.P.

CG SUBSIDIARY HOLDINGS L.L.C.

TC GROUP, LLC

CARLYLE INVESTMENT MANAGEMENT LLC

CARLYLE GENESIS UK LLC

  • 10% Owner
 5,628,558 2022-08-01 2

EMSTER KURT VON

  • Director
  • 10% Owner
 78,045 2022-03-21 0

ABINGWORTH LLP

  • 10% Owner
 5,628,558 2022-03-21 0

LIS WILLIAM SEE REMARKS

  • Officer
  • Director
 287,444 2022-03-21 0

KLEIN LAWRENCE OTTO

  • Director
 78,045 2022-03-21 0

HELLER KEVIN N. SEE REMARKS

  • Officer
 7,500 2022-03-21 0

NOLET CHRIS

  • Director
 78,045 2022-03-21 0

FRENCH ANNA LOUISE

  • Director
 78,045 2022-03-21 0

SHIZURU JUDITH ANNE

  • Director
 78,045 2022-03-21 0

VENKATARAMAN BALAJI

  • FORMER DIRECTOR AND OFFICER
 2,300,000 2021-09-24 1

HOFFEN HOWARD I

  • FORMER DIRECTOR
 2,300,000 2021-09-24 0

QIMING U.S. HEALTHCARE FUND II, L.P.

QIMING U.S. HEALTHCARE GP II, LLC

MCDADE MARK

  • 10% Owner
 5,852,982 2021-09-24 0

CLIFFORD KENNETH F

  • FORMER OFFICER
 2,300,000 2021-09-24 0

GLAZER CAPITAL, LLC

GLAZER PAUL J

  • 10% Owner
 No longer subject to file 2021-04-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MARTELL RON - Director - Officer PRESIDENT, CEO AND DIRECTOR

2023-03-20 17:59:47 -0400 2023-03-17 A 500,000 a 500,000 direct

MAHAL JEETINDER SINGH - Officer SEE REMARKS

2023-03-20 18:00:57 -0400 2023-03-17 A 350,000 a 350,000 direct

KAPOOR VISHAL - Director

2023-02-17 08:30:07 -0500 2023-02-16 A 109,383 a 109,383 direct

MARTELL RON - Director - Officer PRESIDENT, CEO & DIRECTOR

2023-02-03 16:13:55 -0500 2023-02-02 A 1,093,831 a 1,093,831 direct

CARLYLE GROUP INC. - > 10% Owner see footnotes

ABINGWORTH LLP - > 10% Owner see footnotes

CARLYLE HOLDINGS I GP INC. - > 10% Owner see footnotes

CARLYLE HOLDINGS I GP SUB L.L.C. - > 10% Owner see footnotes

CARLYLE HOLDINGS I L.P. - > 10% Owner see footnotes

CG SUBSIDIARY HOLDINGS L.L.C. - > 10% Owner see footnotes

TC GROUP, LLC - > 10% Owner see footnotes

CARLYLE INVESTMENT MANAGEMENT LLC - > 10% Owner see footnotes

CARLYLE GENESIS UK LLC - > 10% Owner see footnotes

2023-01-31 17:24:21 -0500 2023-01-27 P 3,133,333 $1.50 a 8,761,891 indirect 7.8788 12.1212 9.0909 26.0606 24 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
JASPER THERAPEUTICS INC JSPR 2023-03-24 22:15:03 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 21:45:03 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 21:15:03 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 20:45:03 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 20:15:04 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 19:45:03 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 19:15:04 UTC -59.6686 64.4886 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 18:45:04 UTC -59.5171 64.3371 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 18:15:03 UTC -59.5171 64.3371 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 17:45:03 UTC -59.5171 64.3371 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 17:15:03 UTC -59.5171 64.3371 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 16:45:03 UTC -59.5171 64.3371 250000
JASPER THERAPEUTICS INC JSPR 2023-03-24 16:15:03 UTC -59.5171 64.3371 200000
JASPER THERAPEUTICS INC JSPR 2023-03-24 15:45:03 UTC -59.5171 64.3371 200000
JASPER THERAPEUTICS INC JSPR 2023-03-24 15:15:03 UTC -59.5171 64.3371 200000
JASPER THERAPEUTICS INC JSPR 2023-03-24 14:45:03 UTC -59.5171 64.3371 200000
JASPER THERAPEUTICS INC JSPR 2023-03-24 14:15:03 UTC -59.5171 64.3371 150000
JASPER THERAPEUTICS INC JSPR 2023-03-24 13:45:03 UTC -59.6749 64.2449 150000
JASPER THERAPEUTICS INC JSPR 2023-03-24 13:15:04 UTC -59.6749 64.2449 150000
JASPER THERAPEUTICS INC JSPR 2023-03-24 12:45:03 UTC -59.6749 64.2449 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments